As of 2025-02-16, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.93. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 68.02 mil USD. AXDX's TTM EBITDA according to its financial statements is -35.25 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 18.2x - 20.2x | 18.8x |
Forward P/E multiples | 21.1x - 22.7x | 21.9x |
Fair Price | (31.19) - (30.03) | (30.19) |
Upside | -2743.0% - -2645.1% | -2658.3% |
Date | EV/EBITDA |
2025-02-10 | -1.97 |
2025-02-07 | -1.99 |
2025-02-06 | -1.99 |
2025-02-05 | -1.99 |
2025-02-04 | -2.02 |
2025-02-03 | -2.03 |
2025-01-31 | -2.05 |
2025-01-30 | -2.03 |
2025-01-29 | -2.02 |
2025-01-28 | -1.97 |
2025-01-27 | -2.08 |
2025-01-24 | -1.92 |
2025-01-23 | -1.91 |
2025-01-22 | -1.89 |
2025-01-21 | -1.89 |
2025-01-17 | -1.85 |
2025-01-16 | -1.89 |
2025-01-15 | -1.89 |
2025-01-14 | -1.86 |
2025-01-13 | -1.89 |
2025-01-10 | -1.94 |
2025-01-08 | -1.88 |
2025-01-07 | -1.92 |
2025-01-06 | -1.96 |
2025-01-03 | -2.05 |
2025-01-02 | -1.99 |
2024-12-31 | -1.94 |
2024-12-30 | -1.91 |
2024-12-27 | -1.87 |
2024-12-26 | -1.88 |
2024-12-24 | -1.85 |
2024-12-23 | -1.87 |
2024-12-20 | -1.92 |
2024-12-19 | -1.94 |
2024-12-18 | -1.94 |
2024-12-17 | -1.91 |
2024-12-16 | -1.94 |
2024-12-13 | -2.02 |
2024-12-12 | -2.05 |
2024-12-11 | -2.03 |
2024-12-10 | -2.10 |
2024-12-09 | -2.16 |
2024-12-06 | -2.21 |
2024-12-05 | -2.21 |
2024-12-04 | -2.30 |
2024-12-03 | -2.21 |
2024-12-02 | -2.26 |
2024-11-29 | -2.27 |
2024-11-27 | -2.23 |
2024-11-26 | -2.26 |